Tag: artificial intelligence (ai) in predictive toxicology market growth

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the Artificial Intelligence (AI) In Predictive Toxicology Market Heading Into 2029?

The market size of artificial intelligence (AI) in predictive toxicology has seen immense growth of late. The market is expected to expand from $0.5 billion in 2024 to $0.64 billion in 2025, with a compound annual growth rate (CAGR) of 29.5%. Factors that have contributed to the growth in the historical period include increased regulatory expectations for toxicity evaluation, greater awareness regarding chemical safety risks, the presence of extensive datasets valuable for model training, growing expenses and ethical issues related to animal testing, and demand for more rapid, cost-efficient toxicity screening procedures.

The growth projections for the artificial intelligence (AI) in predictive toxicology market are truly impressive. It is believed that the market will skyrocket to “$1.83 billion by the end of 2029, increasing at a compound annual growth rate (CAGR) of 29.9%.” Certain elements are propelling this surge, including the adoption of explainable AI in toxicology predictions, an increasing demand for individualized toxicity evaluations and the regulatory acceptance of AI-based toxicity predictions. This is in addition to the enlargement of AI applications in pharmaceutical research and the rise of predictive toxicology outsourcing services. Future trends likely to dominate this period are a shift to 3D cell culture methods for toxicity exams, an increase in federated learning approaches for shared toxicity predictions, and the uses of generative models in predicting chemical toxicity paths. Additionally, the integration of natural language processing for gleaning toxicity data from documentation, and the advancement of virtual screening platforms for choosing chemical testing, are also anticipated.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14253&type=smp

Which Factors Are Pushing The Artificial Intelligence (AI) In Predictive Toxicology Market Forward?

Anticipated growth in the artificial intelligence (AI) in predictive toxicology market is largely due to the rising necessity for efficient and ethical drug discovery methods. Drug discovery is a multifaceted and evolving procedure involving the detailed study, production, and assessment of chemical compounds in order to unearth viable therapeutic agents for disease relief and general health improvement. This advanced and responsible approach to drug discovery is motivated by the growing prevalence of chronic illnesses, the emerging trend toward personalized medicine and an increase in age-related diseases. AI in predictive toxicology enhances drug discovery by proficiently examining extensive datasets to anticipate potential toxicological results, thus expediting the drug development process while upholding ethical practices. As an illustration, in June 2023, the pharmaceutical R&D expenditure in Europe was reported to be $49,500 million (€44,500 million), a roughly 6.45% increase from $46,500 million (€42,533 million) in 2021, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based pharmaceutical industry trade association. This growing necessity for efficient and ethical drug discovery procedures, therefore, is fueling the rise of AI in predictive toxicology market.

The artificial intelligence (ai) in predictive toxicology market covered in this report is segmented –

1) By Component: Solution, Services

2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Other Technologies

3) By Toxicity Endpoints: Genotoxicity, Hepatotoxicity, Neurotoxicity, Cardiotoxicity, Other Toxicity Endpoints

4) By End User: Pharmaceutical And Biotechnology Companies, Chemical And Cosmetics, Contract Research Organizations, Other End Users

Subsegments:

1) By Solution: Software Platforms, Data Analysis Tools, Predictive Modeling Solutions, Database And Information Systems

2) By Services: Consulting Services, Training And Support Services, Data Management And Integration Services, Research And Development Services

What Long-Term Trends Are Likely To Affect The Artificial Intelligence (AI) In Predictive Toxicology Market?

Key players in the AI predictive toxicology sector are embracing tactical partnerships for innovation and expanding their market footprint. The objective is to leverage artificial intelligence and machine learning methodologies to enhance the prediction and evaluation of chemical and pharmaceutical toxicity. For instance, in January 2024, SyntheticGestalt, a UK-based firm specializing in AI research and development for drug discovery, inked a partnership with Enamine, a Ukraine-based supplier of chemical building blocks, screening components, and integrated drug discovery services. The partnership aims to create AI models that will streamline the creation of biologically active compounds that are synthetically accessible, optimizing their physicochemical and ADME or Tox attributes. These models will be utilized in SyntheticGestalt’s compound discovery ventures, providing services to both academic entities and pharmaceutical companies. Enamine has granted access to its comprehensive Enamine REAL database, which houses 38 billion molecules. SyntheticGestalt plans to incorporate this database into its Drug Discovery Service, using proprietary AI models to estimate the physicochemical and ADME or Tox attributes of compounds. The service will immediately propose superior alternatives for compounds with issues.

Which Organizations Are Driving Progress In The Artificial Intelligence (AI) In Predictive Toxicology Industry?

Major companies operating in the artificial intelligence (AI) in predictive toxicology market are Laboratory Corporation of America Holdings (LabCorp), Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International, Medidata Solutions Inc., Certara Inc., Schrödinger, Merative L.P., Molecular Devices LLC, Envigo (Inotiv Inc.), Instem plc, Simulations Plus, Cyprotex, Recursion Pharmaceuticals, Exscientia PLC, BIOVIA Corporation, Lhasa Limited, Chemaxon Ltd., Insilico Medicine Inc., Algorithme Pharma, CiToxLAB, ArisGlobal, Benevolent AI, Berg Health, Cyclica Therapeutics Inc., Celsius Therapeutics, Biovista Inc., BioTeam Inc.

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

Which Region Is Expected To Experience The Highest Growth In The Artificial Intelligence (AI) In Predictive Toxicology Industry?

North America was the largest region in the artificial intelligence (AI) in predictive toxicology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in predictive toxicology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=14253&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Artificial Intelligence (AI) In Predictive Toxicology Market Through 2034?

The market size of artificial intelligence (AI) in predictive toxicology has seen a rapid expansion in recent times. The market which was valued at $0.5 billion in 2024 is projected to increase to $0.64 billion in 2025, showcasing a compound annual growth rate (CAGR) of 29.5%. Factors driving this growth during the previous period include heightened regulatory demands related to toxicity evaluation, escalating apprehensions about chemical safety, the existence of extensive datasets for model training, increasing expenses and ethical issues linked to animal testing, and the requirement for swifter, more cost-efficient toxicity screening procedures.

In the coming years, the artificial intelligence (AI) market in predictive toxicology is set to experience a significant surge in size, escalating to a market value of $1.83 billion in 2029, with a compound annual growth rate (CAGR) of 29.9%. This anticipated expansion in the forecast period is largely due to factors such as the rise of explainable AI technology for toxicity predictions, an increasing demand for tailored toxicity assessments, recognition and standardization of AI-enabled toxicity predictions by regulatory bodies, an upswing in outsourced predictive toxicology services, and a broadened utility of AI in the sectors of drug discovery and development. The forecasting period will also witness several key trends, such as a shift towards using 3D cell culture models for toxicity tests, the emergence of federated learning strategies for joint toxicity prediction, the use of generative models for mapping out chemical toxicity pathways, the application of natural language processing to extract toxicity information from written sources, and increased precedence of virtual screening platforms to prioritize chemical testing.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14253&type=smp

Which Factors and External Forces Are Driving Demand in the Artificial Intelligence (AI) In Predictive Toxicology Market?

The escalating need for efficient and morally acceptable drug discovery processes is anticipated to fuel the expansion of the artificial intelligence (AI) in predictive toxicology market in the future. The complexity and fluidity of drug discovery, a process involving the careful investigation, creation, and assessment of chemical compounds to unearth potential therapeutic agents for disease relief and overall health improvement is noteworthy. Efficient and ethical drug discovery calls for the adoption of superior technologies and an emphasis on conscientious research to generate new therapeutic agents. The rising instances of chronic diseases, the burgeoning move towards personalized medicine, and the growing prevalence of aging-related diseases fuel the demand for such efficient and ethical drug discovery. AI’s role in predictive toxicology boosts drug discovery by adeptly analyzing huge datasets to forecast possible toxicological outcomes, thus accelerating drug development while adhering to ethical norms. For example, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a trade body based in Belgium, representing the pharmaceutical sector, reported that in June 2023, the overall pharmaceutical R&D expenditure in Europe reached $49,500 million (€44,500 million) in 2022, a climb of about 6.45% from $46,500 million (€42,533 million) in 2021. Hence, the mounting demand for such efficient and morally sound drug discovery processes fuels the expansion of the AI in predictive toxicology market.

Which Segments in the Artificial Intelligence (AI) In Predictive Toxicology Offer the Most Growth?

The artificial intelligence (ai) in predictive toxicology market covered in this report is segmented –

1) By Component: Solution, Services

2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Other Technologies

3) By Toxicity Endpoints: Genotoxicity, Hepatotoxicity, Neurotoxicity, Cardiotoxicity, Other Toxicity Endpoints

4) By End User: Pharmaceutical And Biotechnology Companies, Chemical And Cosmetics, Contract Research Organizations, Other End Users

Subsegments:

1) By Solution: Software Platforms, Data Analysis Tools, Predictive Modeling Solutions, Database And Information Systems

2) By Services: Consulting Services, Training And Support Services, Data Management And Integration Services, Research And Development Services

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=14253&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Artificial Intelligence (AI) In Predictive Toxicology Market?# Market?

North America was the largest region in the artificial intelligence (AI) in predictive toxicology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in predictive toxicology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theArtificial Intelligence (AI) In Predictive Toxicology Market’s Growth?

Companies that are significant players in the AI predictive toxicology market are using collaborative strategies to expand their market reach and spur innovation. This cooperation aims to employ AI and machine learning methods to better predict and evaluate the toxicity of chemical compounds and drugs. For instance, SyntheticGestalt, a UK-based company specializing in AI research and development with a focus on AI drug discovery solutions, teamed up with Ukraine-based Enamine, a supplier of chemical building blocks, screening compounds, and all-in-one drug discovery services, in January 2024. Their goal was to create a series of AI models to streamline the production of biologically active compounds that can be synthesized easily, and to optimize their physical and chemical, and ADME or Tox (Absorption, Distribution, Metabolism, and Excretion or Toxicity) characteristics. These models will be used in SyntheticGestalt’s endeavors to discover compounds, providing a service both to academia and pharmaceutical firms. Enamine has given access to its vast Enamine REAL database, which houses 38 billion molecules. The data will be incorporated into SyntheticGestalt’s Drug Discovery Service, where it will use distinct AI models to predict the physical and chemical, and ADME or Tox features of compounds. This service will quickly propose enhanced replacement compounds for those that present problems.

View the full report here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

What Are the Key Elements That Define the Artificial Intelligence (AI) In Predictive Toxicology Market?

Artificial intelligence (AI) in predictive toxicology refers to the use of artificial intelligence techniques to analyze biological, chemical, and environmental data to predict the potential toxicity of chemicals and compounds. It is used to expedite chemical safety assessments, predict drug toxicity, and prioritize chemicals for further testing.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14253

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Artificial Intelligence (AI) In Predictive Toxicology Market from 2024 to 2025?

There has been significant growth in recent years in the size of the market for artificial intelligence (AI) in predictive toxicology. It is predicted to expand from $0.5 billion in 2024 to $0.64 billion in 2025, representing a compound annual growth rate (CAGR) of 30.0%. The increase during the historical period can be linked to amplified regulatory scrutiny regarding toxicity evaluation, heightened worries about the safety of chemicals, access to extensive datasets for model training, the rising expense and ethical questions around animal testing, and the need for quicker and more economical methods of toxicity screening.

What Is the Projected Market Size of the Artificial Intelligence (AI) In Predictive Toxicology Market?

Predictions anticipate a significant increase in the size of the artificial intelligence (AI) market in predictive toxicology. In the coming years, the market could reach a whopping $1.84 billion in 2029, growing at a compound annual growth rate (CAGR) of 30.0%. Numerous factors, such as the advent of explainable AI in toxicology predictions, the need for personalized toxicity evaluations, the standardization and regulatory approval of AI-based toxicity expectations, the increase in outsourcing services for predictive toxicology, and the widening applications of AI in drug discovery and development, contribute to growth during the forecast period. The era is marked by noticeable trends such as the convergence towards 3D cell culture models for toxicity testing, the emergence of federated learning methods for cooperative toxicity prediction, the utilization of generative models for forecasting chemical toxicity pathways, the integration of natural language processing for toxicity data extraction from literature, and the growth of virtual screening platforms for prioritizing chemical testing.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14253&type=smp

Who are the Major Competitors in the Artificial Intelligence (AI) In Predictive Toxicology Market Outlook?

Major companies operating in the artificial intelligence (AI) in predictive toxicology market are Laboratory Corporation of America Holdings (LabCorp), Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International, Medidata Solutions Inc., Certara Inc., Schrödinger, Merative L.P., Molecular Devices LLC, Envigo (Inotiv Inc.), Instem plc, Simulations Plus, Cyprotex, Recursion Pharmaceuticals, Exscientia PLC, BIOVIA Corporation, Lhasa Limited, Chemaxon Ltd., Insilico Medicine Inc., Algorithme Pharma, CiToxLAB, ArisGlobal, Benevolent AI, Berg Health, Cyclica Therapeutics Inc., Celsius Therapeutics, Biovista Inc., BioTeam Inc.

What Is Fueling Growth in the Artificial Intelligence (AI) In Predictive Toxicology Market?

The surge in demand for more effective and ethical procedures in drug discovery is predicted to stimulate the expansion of the artificial intelligence (AI) in predictive toxicology market. The intricate and evolving nature of drug discovery, which includes comprehensive examinations, creation, and testing of chemical compounds to identify potential treatment agents to combat diseases and improve overall health, triggers the requirement for efficient and ethical drug discovery processes. The said processes employ cutting-edge tech and conscientious research methods to manufacture new medicinal agents. The growing incidents of chronic illnesses, the increasing inclination towards personalized treatment, and higher prevalence of illnesses related to aging drive the demand for these processes. Predictive toxicology powered by AI boosts the drug discovery systems by competently scrutinizing extensive data sets, which helps to foresee possible toxicological outcomes. This hastens the drug development process while also maintaining ethical standards. For example, the Belgium-based European Federation of Pharmaceutical Industries and Associations (EFPIA) reported in June 2023 that Europe’s total pharmaceutical R&D expenditure amounted to $49,500 million (€44,500 million) in 2022, which marks an increase of roughly 6.45% from $46,500 million (€42,533 million) in 2021. As a result, the booming demand for efficient and ethical processes in drug discovery is propelling the growth of the AI in predictive toxicology market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=14253&type=smp

Which Artificial Intelligence (AI) In Predictive Toxicology Market Segments Are Growing the Fastest?

The artificial intelligence (AI) in predictive toxicology market covered in this report is segmented –

1) By Component: Solution, Services

2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Other Technologies

3) By Toxicity Endpoints: Genotoxicity, Hepatotoxicity, Neurotoxicity, Cardiotoxicity, Other Toxicity Endpoints

4) By End User: Pharmaceutical And Biotechnology Companies, Chemical And Cosmetics, Contract Research Organizations, Other End Users

Subsegments:

1) By Solution: Software Platforms, Data Analysis Tools, Predictive Modeling Solutions, Database And Information Systems

2) By Services: Consulting Services, Training And Support Services, Data Management And Integration Services, Research And Development Services

Which Industry Trends Are Shaping the Future of the Artificial Intelligence (AI) In Predictive Toxicology Market?

A trend in the AI predictive toxicology market is for major industry players to boost their market share and spur innovation through strategic collaborations. These partnerships aim to elevate the prediction and analysis of chemical and pharmaceutical toxicity through the use of artificial intelligence and machine learning. For instance, a UK-based AI research and development firm, SyntheticGestalt, known for its AI drug discovery solutions, fused its operations with Enamine, a Ukraine-based company supplying chemical building blocks and drug discovery services, in January 2024. They then jointly developed AI models designed to generate synthetically accessible biologically active compounds and optimize their physicochemical and ADME/Tox (Absorption, Distribution, Metabolism, and Excretion or Toxicity) attributes. These models will be used in SyntheticGestalt’s compound discovery work, for the benefit of both academic researchers and pharmaceutical companies. Enamine has made their extensive Enamine REAL database, complete with 38 billion molecules, available as part of this partnership. This database will be incorporated into SyntheticGestalt’s Drug Discovery Service, wherein their proprietary AI models will predict the physicochemical and ADME or Tox properties of compounds. This service promises to offer enhanced alternative compounds swiftly for those with complications.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

Which Countries Are Leading the Artificial Intelligence (AI) In Predictive Toxicology Market?

North America was the largest region in the artificial intelligence (AI) in predictive toxicology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in predictive toxicology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14253

This Report Delivers Insight On:

1. How big is the artificial intelligence (ai) in predictive toxicology market, and how is it changing globally?

2. Who are the major companies in the artificial intelligence (ai) in predictive toxicology market, and how are they performing?

3. What are the key opportunities and risks in the artificial intelligence (ai) in predictive toxicology market right now?

4. Which products or customer segments are growing the most in the artificial intelligence (ai) in predictive toxicology market?

5. What factors are helping or slowing down the growth of the artificial intelligence (ai) in predictive toxicology market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Artificial Intelligence (AI) In Predictive Toxicology Market?

The artificial intelligence (AI) in predictive toxicology market is anticipated to grow due to rising demand for efficient and ethical drug discovery processes. Drug discovery is a complex and fluid process within which chemical compounds are systematically examined, created, and assessed to find potential treatments to ameliorate illnesses and enhance general well-being. Efficient and ethical drug discovery, on the other hand, employs advanced technologies and adopts responsible research methods for the design of novel therapeutic agents. The need for these processes is fueled by increasing chronic illnesses, the growing interest in personalized medicine, and the escalating prevalence of age-related diseases. AI in predictive toxicology heightens the effectiveness of drug discovery by swiftly analyzing vast amounts of data to forecast possible toxicology outcomes, hence fast-tracking drug development while also ensuring that ethical norms are upheld. For instance, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade group reflecting the interests of the pharmaceutical sector, stated in June 2023 that the overall pharmaceutical R&D expenditure in Europe came to $49,500 million (€44,500 million) in 2022, a rise of around 6.45% from $46,500 million (€42,533 million) in 2021. As such, it’s clear that the progressively escalating demand for efficient and ethically sound drug discovery processes is fueling the growth of the AI in predictive toxicology market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14253&type=smp

#How Will the CAGR of the Artificial Intelligence (AI) In Predictive Toxicology Market Influence Its Overall Growth by 2034?

The market size of artificial intelligence (AI) in predictive toxicology has witnessed an exponential surge in the past few years. Projected to expand from $0.5 billion in 2024 to $0.64 billion in 2025, it yields a compound annual growth rate (CAGR) of 30.0%. Factors that have contributed to the development during the historic period include higher regulatory scrutiny on toxicity assessment, heightened awareness about chemical safety, the presence of vast data sets for model training, the increase of costs and moral issues tied with animal testing, and the rising demand for quicker and more economical toxicity screening methods.

The market for artificial intelligence (AI) in predictive toxicology is projected to witness significant expansion in the coming years, growing to $1.84 billion in 2029 at a 30.0% compound annual growth rate (CAGR). This projected growth during the forecast period can be credited to the development of explainable AI in toxicology forecasts, the rising demand for customized toxicity evaluations, the regulatory approval and standardization of AI-driven toxicity forecasts, an increase in outsourcing services for predictive toxicology, and the broadening of AI applications in drug discovery and development. Key trends during this period will include a shift towards 3D cell culture models for toxicity examination, the rise of federated learning techniques for communal toxicity forecasts, the use of generative models to predict chemical toxicity routes, the application of natural language processing to gather toxicity data from literature, and the emergence of virtual screening platforms for chemical testing prioritization.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14253

What New Market Trends Are Reshaping theArtificial Intelligence (AI) In Predictive Toxicology Market and Its Opportunities?

Prominent companies in the AI predictive toxicology market are adopting strategies involving strategic alliances to strengthen their market position and drive innovation. The focus of these collaborations is to use AI and machine learning to enhance the prediction and evaluation of chemical and pharmaceutical toxicity. For example, in January 2024, UK-based AI drug discovery firm SyntheticGestalt partnered with Ukraine’s Enamine, which offers chemical building blocks and integrated drug discovery services. The partnership was aimed at creating AI models that streamline the production of biologically active, synthetically accessible compounds, while optimizing their physicochemical and ADME or Tox properties. These models will be applied in SyntheticGestalt’s compound discovery ventures, serving both academic entities and pharmaceutical firms through their services. Enamine made their comprehensive Enamine REAL database, with 38 billion molecules, accessible for this endeavor. SyntheticGestalt plans to incorporate this database into their Drug Discovery Service, making use of proprietary AI models to predict the physicochemical and ADME or Tox properties of compounds. The service will promptly propose better alternatives for compounds with issues.

Who Are the Leading Market Players Fueling Growth in the Artificial Intelligence (AI) In Predictive Toxicology Market Trend?

Major companies operating in the artificial intelligence (AI) in predictive toxicology market are Laboratory Corporation of America Holdings (LabCorp), Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International, Medidata Solutions Inc., Certara Inc., Schrödinger, Merative L.P., Molecular Devices LLC, Envigo (Inotiv Inc.), Instem plc, Simulations Plus, Cyprotex, Recursion Pharmaceuticals, Exscientia PLC, BIOVIA Corporation, Lhasa Limited, Chemaxon Ltd., Insilico Medicine Inc., Algorithme Pharma, CiToxLAB, ArisGlobal, Benevolent AI, Berg Health, Cyclica Therapeutics Inc., Celsius Therapeutics, Biovista Inc., BioTeam Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

How is the Global Artificial Intelligence (AI) In Predictive Toxicology Market Segemented?

The artificial intelligence (AI) in predictive toxicology market covered in this report is segmented –

1) By Component: Solution, Services

2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Other Technologies

3) By Toxicity Endpoints: Genotoxicity, Hepatotoxicity, Neurotoxicity, Cardiotoxicity, Other Toxicity Endpoints

4) By End User: Pharmaceutical And Biotechnology Companies, Chemical And Cosmetics, Contract Research Organizations, Other End Users

Subsegments:

1) By Solution: Software Platforms, Data Analysis Tools, Predictive Modeling Solutions, Database And Information Systems

2) By Services: Consulting Services, Training And Support Services, Data Management And Integration Services, Research And Development Services

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=14253&type=smp

Which Geographics are Influencing the Growth of the Artificial Intelligence (AI) In Predictive Toxicology Market?

North America was the largest region in the artificial intelligence (AI) in predictive toxicology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in predictive toxicology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Predictive Toxicology Market 2025, By The Business Research Company:

Artificial Intelligence Chip Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-chip-global-market-report

Artificial Intelligence (Chipsets) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-chipsets-global-market-report

Artificial Intelligence (AI) in Precision Medicine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-precision-medicine-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the artificial intelligence (ai) in predictive toxicology market grown in recent years?

There has been a significant expansion in the artificial intelligence (AI) in predictive toxicology market over the past few years. The market’s growth trajectory sees it increasing from $0.5 billion in 2024 to $0.64 billion in 2025, with a compound annual growth rate (CAGR) of 30.0%. This expansion in the previous period is linked to heightened regulatory scrutiny over toxicity assessment, mounting worries about the safety of chemicals, the accessibility of extensive datasets for model training, the surge in costs and ethical issues related to animal testing, and the necessity for quicker and more affordable methods of toxicity screening.

How is the artificial intelligence (ai) in remote patient monitoring market size expected to evolve during the forecast period?

There is expected to be a significant expansion in the size of the artificial intelligence (AI) in predictive toxicology market over the next few years, with projected growth to $1.84 billion in 2029 and an estimated compound annual growth rate (CAGR) of 30.0%. Key factors contributing to this growth during the forecast period include the introduction of explainable AI in toxicity forecasts, the increasing demand for individual toxicity evaluations, the regulatory approval and standardization of AI-driven toxicity predictions, the surge in outsourcing services for predictive toxicology, and the proliferation of AI’s role in drug discovery and development. Upcoming market trends for this period include the transition to 3D cell culture models for toxicity tests, the emergence of federated learning methodologies for cooperative toxicity forecasts, the use of generative models for forecasting chemical toxicity pathways, the inclusion of natural language processing for toxicity data extraction from academic sources, and the expansion of virtual screening platforms for prioritizing chemical tests.

Get your artificial intelligence (ai) in predictive toxicology market report here!

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

Which key drivers are propelling the artificial intelligence (ai) in predictive toxicology market’s growth?

The growth of artificial intelligence (AI) in the predictive toxicology market is set to be fueled by escalating demand for effective and ethical drug discovery procedures. Drug discovery, a complex and fluctuating process involving seamless exploration, synthesis, and review of chemical compounds to identify potential therapeutic agents for disease relief and general health improvement, necessitates the use of leading-edge technologies and the commitment to conscientious research practices. This surge in demand for efficient and ethical drug discovery is influenced by increasing chronic illnesses, a rising inclination towards personalized healthcare, and an escalating incidence of diseases linked to aging. AI’s role in predictive toxicology significantly optimizes the drug discovery process by evaluating large amounts of data to forecast potential toxicological results, thus speeding drug development and ensuring compliance with ethical norms. For example, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based pharmaceutical industry representative, reported that total pharmaceutical R&D expenditure in Europe reached $49,500 million (€44,500 million) in 2022, marking an approximate increase of 6.45% from $46,500 million (€42,533 million) in 2021. Consequently, this rise in demand for efficient and ethical drug discovery is propelling the expansion of the AI in predictive toxicology market.

What are the market segments in the artificial intelligence (ai) in predictive toxicology industry?

The artificial intelligence (AI) in predictive toxicology market covered in this report is segmented –

1) By Component: Solution, Services

2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Other Technologies

3) By Toxicity Endpoints: Genotoxicity, Hepatotoxicity, Neurotoxicity, Cardiotoxicity, Other Toxicity Endpoints

4) By End User: Pharmaceutical And Biotechnology Companies, Chemical And Cosmetics, Contract Research Organizations, Other End Users

Subsegments:

1) By Solution: Software Platforms, Data Analysis Tools, Predictive Modeling Solutions, Database And Information Systems

2) By Services: Consulting Services, Training And Support Services, Data Management And Integration Services, Research And Development Services

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14253&type=smp

Which leading companies are shaping the growth of the artificial intelligence (ai) in predictive toxicology market?

Major companies operating in the artificial intelligence (AI) in predictive toxicology market are Laboratory Corporation of America Holdings (LabCorp), Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International, Medidata Solutions Inc., Certara Inc., Schrödinger, Merative L.P., Molecular Devices LLC, Envigo (Inotiv Inc.), Instem plc, Simulations Plus, Cyprotex, Recursion Pharmaceuticals, Exscientia PLC, BIOVIA Corporation, Lhasa Limited, Chemaxon Ltd., Insilico Medicine Inc., Algorithme Pharma, CiToxLAB, ArisGlobal, Benevolent AI, Berg Health, Cyclica Therapeutics Inc., Celsius Therapeutics, Biovista Inc., BioTeam Inc.

What key trends are currently impacting the artificial intelligence (ai) in predictive toxicology market’s development?

Leading businesses in the AI predictive toxicology market are deploying strategic partnership tactics to strengthen their market foothold and spur innovation. These partnerships intend to harness AI and machine learning skills to enhance the forecasting and appraisal of the toxicity of chemical and pharmaceutical compounds. For example, in January 2024, the UK’s SyntheticGestalt, an AI research and development firm specializing in AI drug discovery solutions, formed an alliance with Enamine, a Ukrainian supplier of chemical building blocks, screening compounds, and comprehensive drug discovery services. They are working together to create AI models that facilitate the formation of biologically active compounds that are easily synthesized, maximizing their physicochemical and ADME or Tox attributes. SyntheticGestalt will use these models for their compound discovery ventures, serving both academia and the pharmaceutical industry through their services. Enamine has offered access to its expansive Enamine REAL database, which contains 38 billion molecules. SyntheticGestalt will incorporate this database into its Drug Discovery Service, using proprietary AI models to estimate the physicochemical and ADME or Tox characteristics of compounds. This service will swiftly propose superior substitute compounds to replace those with problems.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14253

Which geographic areas are influencing the growth of the artificial intelligence (ai) in predictive toxicology market?

North America was the largest region in the artificial intelligence (AI) in predictive toxicology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in predictive toxicology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Artificial Intelligence Chip Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-chip-global-market-report

Artificial Intelligence (Chipsets) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-chipsets-global-market-report

Artificial Intelligence (AI) in Precision Medicine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-precision-medicine-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the artificial intelligence (ai) in predictive toxicology market grown in recent years?

There has been a significant expansion in the artificial intelligence (AI) in predictive toxicology market over the past few years. The market’s growth trajectory sees it increasing from $0.5 billion in 2024 to $0.64 billion in 2025, with a compound annual growth rate (CAGR) of 30.0%. This expansion in the previous period is linked to heightened regulatory scrutiny over toxicity assessment, mounting worries about the safety of chemicals, the accessibility of extensive datasets for model training, the surge in costs and ethical issues related to animal testing, and the necessity for quicker and more affordable methods of toxicity screening.

How is the artificial intelligence (ai) in remote patient monitoring market size expected to evolve during the forecast period?

There is expected to be a significant expansion in the size of the artificial intelligence (AI) in predictive toxicology market over the next few years, with projected growth to $1.84 billion in 2029 and an estimated compound annual growth rate (CAGR) of 30.0%. Key factors contributing to this growth during the forecast period include the introduction of explainable AI in toxicity forecasts, the increasing demand for individual toxicity evaluations, the regulatory approval and standardization of AI-driven toxicity predictions, the surge in outsourcing services for predictive toxicology, and the proliferation of AI’s role in drug discovery and development. Upcoming market trends for this period include the transition to 3D cell culture models for toxicity tests, the emergence of federated learning methodologies for cooperative toxicity forecasts, the use of generative models for forecasting chemical toxicity pathways, the inclusion of natural language processing for toxicity data extraction from academic sources, and the expansion of virtual screening platforms for prioritizing chemical tests.

Get your artificial intelligence (ai) in predictive toxicology market report here!

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

Which key drivers are propelling the artificial intelligence (ai) in predictive toxicology market’s growth?

The growth of artificial intelligence (AI) in the predictive toxicology market is set to be fueled by escalating demand for effective and ethical drug discovery procedures. Drug discovery, a complex and fluctuating process involving seamless exploration, synthesis, and review of chemical compounds to identify potential therapeutic agents for disease relief and general health improvement, necessitates the use of leading-edge technologies and the commitment to conscientious research practices. This surge in demand for efficient and ethical drug discovery is influenced by increasing chronic illnesses, a rising inclination towards personalized healthcare, and an escalating incidence of diseases linked to aging. AI’s role in predictive toxicology significantly optimizes the drug discovery process by evaluating large amounts of data to forecast potential toxicological results, thus speeding drug development and ensuring compliance with ethical norms. For example, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based pharmaceutical industry representative, reported that total pharmaceutical R&D expenditure in Europe reached $49,500 million (€44,500 million) in 2022, marking an approximate increase of 6.45% from $46,500 million (€42,533 million) in 2021. Consequently, this rise in demand for efficient and ethical drug discovery is propelling the expansion of the AI in predictive toxicology market.

What are the market segments in the artificial intelligence (ai) in predictive toxicology industry?

The artificial intelligence (AI) in predictive toxicology market covered in this report is segmented –

1) By Component: Solution, Services

2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Other Technologies

3) By Toxicity Endpoints: Genotoxicity, Hepatotoxicity, Neurotoxicity, Cardiotoxicity, Other Toxicity Endpoints

4) By End User: Pharmaceutical And Biotechnology Companies, Chemical And Cosmetics, Contract Research Organizations, Other End Users

Subsegments:

1) By Solution: Software Platforms, Data Analysis Tools, Predictive Modeling Solutions, Database And Information Systems

2) By Services: Consulting Services, Training And Support Services, Data Management And Integration Services, Research And Development Services

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14253&type=smp

Which leading companies are shaping the growth of the artificial intelligence (ai) in predictive toxicology market?

Major companies operating in the artificial intelligence (AI) in predictive toxicology market are Laboratory Corporation of America Holdings (LabCorp), Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International, Medidata Solutions Inc., Certara Inc., Schrödinger, Merative L.P., Molecular Devices LLC, Envigo (Inotiv Inc.), Instem plc, Simulations Plus, Cyprotex, Recursion Pharmaceuticals, Exscientia PLC, BIOVIA Corporation, Lhasa Limited, Chemaxon Ltd., Insilico Medicine Inc., Algorithme Pharma, CiToxLAB, ArisGlobal, Benevolent AI, Berg Health, Cyclica Therapeutics Inc., Celsius Therapeutics, Biovista Inc., BioTeam Inc.

What key trends are currently impacting the artificial intelligence (ai) in predictive toxicology market’s development?

Leading businesses in the AI predictive toxicology market are deploying strategic partnership tactics to strengthen their market foothold and spur innovation. These partnerships intend to harness AI and machine learning skills to enhance the forecasting and appraisal of the toxicity of chemical and pharmaceutical compounds. For example, in January 2024, the UK’s SyntheticGestalt, an AI research and development firm specializing in AI drug discovery solutions, formed an alliance with Enamine, a Ukrainian supplier of chemical building blocks, screening compounds, and comprehensive drug discovery services. They are working together to create AI models that facilitate the formation of biologically active compounds that are easily synthesized, maximizing their physicochemical and ADME or Tox attributes. SyntheticGestalt will use these models for their compound discovery ventures, serving both academia and the pharmaceutical industry through their services. Enamine has offered access to its expansive Enamine REAL database, which contains 38 billion molecules. SyntheticGestalt will incorporate this database into its Drug Discovery Service, using proprietary AI models to estimate the physicochemical and ADME or Tox characteristics of compounds. This service will swiftly propose superior substitute compounds to replace those with problems.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14253

Which geographic areas are influencing the growth of the artificial intelligence (ai) in predictive toxicology market?

North America was the largest region in the artificial intelligence (AI) in predictive toxicology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in predictive toxicology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Artificial Intelligence Chip Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-chip-global-market-report

Artificial Intelligence (Chipsets) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-chipsets-global-market-report

Artificial Intelligence (AI) in Precision Medicine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-precision-medicine-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted CAGR for the Artificial Intelligence (AI) In Predictive Toxicology Market Over the Forecast Period of 2025 to 2034?

The market size of artificial intelligence (AI) within predictive toxicology has seen a significant surge in growth in the past few years. An expansion from $0.5 billion in 2024 to $0.64 billion in 2025, with a compound annual growth rate (CAGR) of 30.0% is expected to be witnessed. The phenomenal growth in the historic period is due to reasons such as intensified regulatory scrutiny for toxicity evaluations, escalating worries concerning chemical safety, the accessibility of substantial datasets for model training, mounting costs and ethical issues linked to animal testing, along with the desire for more rapid and economical toxicity screening procedures.

Predicted surges in the artificial intelligence (AI) applied in predictive toxicology market are slated to be substantial over the coming years, with projections indicating a growth to $1.84 billion by 2029, indicating a compound annual growth rate (CAGR) of 30.0%. Factors such as the introduction of explainable AI in toxicological forecasting, the demand for custom toxicity evaluations, acceptance, and normalization of AI-backed toxicity predictions by regulatory bodies, increase in outsourcing services for predictive toxicology, and the broadening of AI usage in drug discovery and development contribute to this escalation during the forecast period. Key trends anticipated during this time include a transition to 3D cell culture models for toxicity tests, the rise of cooperative toxicity prediction through federated learning strategies, the use of generative models for anticipating chemical toxicity pathways, the adoption of natural language processing for collating toxicity data from scholarly literature, and the expansion of virtual screening platforms for prioritizing chemical analysis.

What Market Dynamics Are Playing a Key Role in Accelerating the Growth of the artificial intelligence (ai) in predictive toxicology Market?

The growth of artificial intelligence (AI) in predictive toxicology market is set to be fueled by a surge in the demand for efficient and ethical drug discovery procedures. The complex and evolving nature of drug discovery requires a thorough investigation, creation, and appraisal of chemical compounds, with the aim to concoct potential therapeutic agents that combat diseases and boost general well-being. Efficient and ethical drug discovery employs cutting-edge technologies and emphasizes ethical research practices for the development of new therapeutic agents. This need is amplified by an increase in chronic illnesses, a shift towards personalized medications, and a rise in diseases associated with aging. AI in predictive toxicology augments drug discovery by proficiently examining extensive data to forecast potential toxicological results. This quickens drug development while complying with ethical norms. For example, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based pharmaceutical industry representative, reported in June 2023 that Europe’s total pharmaceutical R&D expenditure was $49,500 million (€44,500 million) in 2022. This marked about a 6.45% growth from the $46,500 million (€42,533 million) documented in 2021. Consequently, the rise in the demand for efficient and ethical drug discovery methods is catalyzing the expansion of the AI in predictive toxicology market.

Explore Comprehensive Insights Into The Global Artificial Intelligence (AI) In Predictive Toxicology Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14253&type=smp

Who Are the Top Companies Driving Innovation and Growth in the Artificial Intelligence (AI) In Predictive Toxicology Market?

Major companies operating in the artificial intelligence (AI) in predictive toxicology market are:

• Laboratory Corporation of America Holdings (LabCorp)_x000D_

• Eurofins Scientific SE_x000D_

• Wuxi AppTec_x000D_

• Charles River Laboratories International_x000D_

• Medidata Solutions Inc._x000D_

What Key Trends Are Currently Impacting the Artificial Intelligence (AI) In Predictive Toxicology Market’s Development?

In an effort to boost their market presence and innovation in the artificial intelligence (AI) predictive toxicology sector, major corporations are turning to strategic partnerships. The focus of these collaborations is to use AI and machine-learning methods to enhance the prediction and evaluation of chemical and pharmaceutical toxicity. Take for instance, the partnership forged in January 2024 between SyntheticGestalt, a UK-based firm specializing in AI-based drug discovery solutions, and Enamine, a Ukrainian company offering chemical building blocks, screening compounds, and comprehensive drug discovery services. Their cooperation centers around creating AI models that expedite the production of synthetically accessible biologically active compounds while optimizing their physicochemical and ADME or Tox (Absorption, Distribution, Metabolism, and Excretion or Toxicity) properties. These models will be used in SyntheticGestalt’s compound discovery projects, benefitting both academic researchers and pharmaceutical firms through their services. Enamine is providing access to its extensive Enamine REAL database, which includes 38 billion molecules, and SyntheticGestalt plans to incorporate this into their Drug Discovery Service. By using in-house AI models, this service will predict the physicochemical and ADME or Tox properties of compounds and swiftly recommend improved alternatives for compounds presenting problems.

Secure Your Global Artificial Intelligence (AI) In Predictive Toxicology Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

What Are the Core Segments of the Artificial Intelligence (AI) In Predictive Toxicology Market, and How Do They Contribute to Growth?

The artificial intelligence (AI) in predictive toxicology market covered in this report is segmented –

1) By Component: Solution, Services

2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Other Technologies

3) By Toxicity Endpoints: Genotoxicity, Hepatotoxicity, Neurotoxicity, Cardiotoxicity, Other Toxicity Endpoints

4) By End User: Pharmaceutical And Biotechnology Companies, Chemical And Cosmetics, Contract Research Organizations, Other End Users

Subsegments:

1) By Solution: Software Platforms, Data Analysis Tools, Predictive Modeling Solutions, Database And Information Systems

2) By Services: Consulting Services, Training And Support Services, Data Management And Integration Services, Research And Development Services

Which Geographical Regions Are Pioneering Growth in the Artificial Intelligence (AI) In Predictive Toxicology Market?

North America was the largest region in the artificial intelligence (AI) in predictive toxicology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in predictive toxicology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Do Experts Define the Scope of the Artificial Intelligence (AI) In Predictive Toxicology Market?

Artificial intelligence (AI) in predictive toxicology refers to the use of artificial intelligence techniques to analyze biological, chemical, and environmental data to predict the potential toxicity of chemicals and compounds. It is used to expedite chemical safety assessments, predict drug toxicity, and prioritize chemicals for further testing.

Browse Through More Similar Reports By The Business Research Company:

Artificial Intelligence Chip Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-chip-global-market-report

Artificial Intelligence (Chipsets) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-chipsets-global-market-report

Artificial Intelligence (AI) in Precision Medicine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-precision-medicine-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: